<DOC>
	<DOCNO>NCT00003680</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining chemotherapy peripheral stem cell transplantation may allow doctor give high dos chemotherapy drug kill tumor cell . It yet know whether high-dose chemotherapy plus peripheral stem cell transplantation effective standard chemotherapy breast cancer . PURPOSE : Randomized phase III trial compare effectiveness standard chemotherapy high-dose chemotherapy plus peripheral stem cell transplantation treat woman advance breast cancer inflammatory breast cancer .</brief_summary>
	<brief_title>Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant Treating Women With Advanced Inflammatory Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare overall survival locally advance , inflammatory , operable large primary breast cancer ( great 3 cm ) patient positive axillary lymph node surgery follow primary chemotherapy , receive either conventional chemotherapy high dose chemotherapy adjuvant therapy . II . Compare relapse-free survival quality life patient receive therapy . OUTLINE : This randomize , multicenter , open label study . Patients stratify study center number positive axillary lymph node surgery . Patients randomize receive conventional high dose adjuvant chemotherapy . Arm I : Patients receive conventional chemotherapy consist cyclophosphamide , methotrexate , fluorouracil IV administer every 3 week 8 course . Arm II : Patients receive high dose chemotherapy . Cyclophosphamide IV administer day 1 . Patients undergo peripheral blood progenitor cell ( PBPC ) collection , receive cyclophosphamide thiotepa IV 4 day , 13-28 day PBPC collection . Peripheral blood progenitor cell reinfused . Patients undergo radiotherapy chemotherapy receive oral tamoxifen 5 year , begin time radiotherapy . Estrogen receptor negative patient may receive tamoxifen discretion treat physician . Quality life assess chemotherapy , 6 , 12 , 24 month . Patients follow 12 , 18 , 24 month , annually 5 year death . PROJECTED ACCRUAL : This study accrue approximately 300 patient .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Inflammatory Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove locally advanced , inflammatory , operable large primary breast cancer ( great 3 cm ) follow 26 course primary anthracyclinecontaining chemotherapy Potentially curative surgery At least 1 axillary lymph node involvement surgery No metastatic disease Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 60 Sex : Female Menopausal status : Not specify Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count great 1500/mm3 Platelet count great 100,000/mm3 Hemoglobin great 9 g/dL Hepatic : Normal prothrombin time Normal activate partial thromboplastin time Normal bilirubin ( except patient benign congenital hyperbilirubinemia ) AST/ALT great 1.5 time upper limit normal ( ULN ) Alkaline phosphatase great 1.5 time ULN No active hepatitis B C infection Renal : Normal creatinine Cardiovascular : Adequate cardiac function No active cardiac disease Left ventricular ejection fraction within normal range Other : No serious medical psychiatric disease Not pregnant No prior/concurrent malignancy except basal cell carcinoma skin carcinoma situ cervix HIV negative OR asymptomatic HIV disease PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Prior surgery require</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>stage III breast cancer</keyword>
	<keyword>inflammatory breast cancer</keyword>
</DOC>